Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors (Q44239761)
Jump to navigation
Jump to search
scientific article published on 9 December 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors |
scientific article published on 9 December 2013 |
Statements
1 reference
Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors (English)
1 reference
Sara M Tolaney
1 reference
Rastislav Bahleda
1 reference
Eunice L Kwak
1 reference
James M Cleary
1 reference
Shuchi S Pandya
1 reference
Antoine Hollebecque
1 reference
Richat Abbas
1 reference
Revathi Ananthakrishnan
1 reference
Anna Berkenblit
1 reference
Mizue Krygowski
1 reference
Yali Liang
1 reference
Kathleen W Turnbull
1 reference
Geoffrey I Shapiro
1 reference
9 December 2013
1 reference
1 reference
Identifiers
1 reference